MIB Startup Studio launches its first call for applications to support immunology startups
Marseille, 25 June 2026 – Marseille Immunology Biocluster is launching the first call for applications for MIB Startup Studio, an initiative designed to support immunology startups in their scientific, strategic and entrepreneurial development.
Created to support high-potential projects, MIB Startup Studio is aimed at already founded startups seeking to accelerate their development within a leading scientific, clinical, technological, industrial and financial ecosystem.
Through this programme, MIB reaffirms its ambition: to help transform scientific discoveries into concrete therapeutic innovations that can reach patients and create lasting value.
Supporting immunology startups through key stages of development
Developing a biotech startup involves many challenges: consolidating the scientific strategy, accessing regulatory and clinical expertise, structuring the business model, identifying industrial partners, preparing for fundraising, and accessing technological platforms.
MIB Startup Studio has been designed to support these critical stages by mobilising the expertise of the Marseille and national ecosystem in immunology, immunotherapies and translational medicine.
Connecting science, healthcare, industry and investment
Rooted in Marseille, MIB brings together academic, hospital, industrial and institutional stakeholders around a shared ambition: accelerating innovation in immunology.
With this first call for applications, the Startup Studio aims to foster synergies between researchers, entrepreneurs, clinicians, investors and industry partners in order to support the emergence of innovative therapeutic solutions.
Apply to the first call for applications
Interested startups are invited to visit the dedicated page to discover the programme, eligibility criteria, timeline and application process.
Partager
Actualités